Moderna CEO Says Covid-19 Vaccine a ‘Game Changer’

The transcript discusses the advantages of a new vaccine in terms of storage and distribution, highlighting its ability to be stored at higher temperatures and without dilution. It covers the logistics of distribution in the US, including partnerships with pharmacies and the military's involvement. The vaccine's efficacy in preventing severe COVID-19 cases is emphasized, along with ongoing studies on its impact on transmission. The adaptability of mRNA technology to mutations is explored, and potential side effects are noted. Future developments in vaccine formulation and commercialization are also discussed.

What are the implications of the vaccine's performance in older populations?

What role does messenger RNA technology play in addressing mutations of the virus?

What side effects have been reported for the vaccine, and how do they compare to other vaccines?

How has the COVID-19 pandemic accelerated the development of other vaccines at Moderna?